Bayer | BAYN - Loan Capital

Stock Price
36.45
Daily Change
-0.17 -0.46%
Monthly
-6.69%
Yearly
58.27%
Q2 Forecast
37.49

Bayer reported EUR31.83B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Air Liquide EUR 11.06B 1.39B Dec/2025
Akzo Nobel EUR 4.76B 1.09B Mar/2026
Alcon AG USD 4.59B 0 Dec/2025
Arkema EUR 3.8B 312M Dec/2025
AstraZeneca USD 25.96B 177M Mar/2026
BASF EUR 18.48B 447M Dec/2025
Bayer EUR 31.83B 877M Dec/2025
Beiersdorf EUR 117M 15M Dec/2025
Corteva USD 1.69B 2M Dec/2025
Covestro EUR 1.67B 408M Dec/2025
Essilor EUR 9.46B 92M Dec/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Fresenius Medical Care EUR 4.85B 4.49B Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GRIFOLS EUR 8.47B 624.81M Dec/2025
Henkel EUR 1.38B 627M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Johnson Matthey GBP 1.34B 3M Dec/2025
Linde USD 20.68B 2.09B Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.73B 277M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Nutrien USD 10.29B 519M Dec/2025
Philips EUR 6.93B 303M Dec/2025
PPG Industries USD 6.41B 195M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
SAP EUR 5.04B 983M Mar/2026
Solvay EUR 1.84B 209M Dec/2025
UCB EUR 2.18B 634M Dec/2025
Umicore EUR 2.24B 10M Dec/2025
Vinci EUR 41.93B 11.14B Dec/2025